bevantolol has been researched along with Chorea Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Calopa, M; Ferré, A; Gamez, J; Huertas, O; Insa, R; Kulisevsky, J; McAllister, K; Muñoz, E; Reig, N; Scart-Grès, C | 1 |
1 trial(s) available for bevantolol and Chorea Disorders
Article | Year |
---|---|
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease.
Topics: Chorea; Double-Blind Method; Humans; Huntington Disease; Tetrabenazine; Treatment Outcome; Vesicular Monoamine Transport Proteins | 2023 |